Natalya Goldshteyn

Natalya Goldshteyn practices at New York-Presbyterian Hospital - Brooklyn HOPD in Brooklyn, New York.

Natalya Goldshteyn's NPI, 1588775183, was assigned on August 31, 2006. Natalya Goldshteyn graduated from Samara State Medical University in 1989. Natalya Goldshteyn's New York license number on file is 231433.

Natalya Goldshteyn's primary practice is New York-Presbyterian Hospital - Brooklyn HOPD, at 506 Sixth Street, Brooklyn, NY 11215.

Natalya Goldshteyn's primary practice is New York-Presbyterian Hospital - Brooklyn HOPD in Brooklyn, New York. Natalya Goldshteyn is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Natalya Goldshteyn to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Natalya Goldshteyn practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Natalya Goldshteyn's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Natalya Goldshteyn is board certified in infectious disease by the American Board of Internal Medicine. Natalya Goldshteyn has a license on file in New York.

Dmand AI lists acute skin infection, hiv/aids and joint or bone infection among the conditions Natalya Goldshteyn treats.

CMS data shows 629 Medicare services from Natalya Goldshteyn across 6 procedure codes in 2024, for 202 Medicare patients. Medicare paid $54,207 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 202 Medicare patients who saw Natalya Goldshteyn in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 65% are also on Medicaid. Their average risk score is 3.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Natalya Goldshteyn's median patient age at 63, with 50% women.

In 2024, Natalya Goldshteyn wrote 634 Medicare Part D claims for 79 patients. CMS names the drug for 468 of them, across 18 drugs with 11 or more claims each, at $1,352,501 in total drug cost. In 2023, CMS named 509 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Natalya Goldshteyn for performance year 2024, reported as part of a group. Natalya Goldshteyn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Natalya Goldshteyn as offering telehealth.

Dmand AI links 2 papers to Natalya Goldshteyn. Natalya Goldshteyn has published most often in South Med J. Natalya Goldshteyn's most frequent co-authors are Rabia Agha, MD, Kenneth Robert Cooke, MD and Liziamma George, MD.

CMS Open Payments shows 52 general payments to Natalya Goldshteyn from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. ViiV Healthcare Company paid the most, $363.

Natalya Goldshteyn graduated from Samara State Medical University in 1989.

Natalya Goldshteyn is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.